Thymmune Therapeutics (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- March 01, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,000,000
Company Info
- Founders
- Bing Lim
- Company Description
- Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.
- Market
- Immunodeficiencies, transplant related, and autoimmune diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- NYBC Ventures, Pillar VC